DTNA anticorps
Aperçu rapide pour DTNA anticorps (ABIN2719781)
Antigène
Voir toutes DTNA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- Homo sapiens dystrobrevin, alpha (DTNA), transcript variant 5
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Full length human recombinant protein of human DTNA (NP_116761) produced in HEK293T cell.
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- WB 1:500~2000, FLOW 1:100
-
Commentaires
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- DTNA (Dystrobrevin alpha (DTNA))
-
Autre désignation
- DTNA
-
Sujet
- The protein encoded by this gene belongs to the dystrobrevin subfamily of the dystrophin family. This protein is a component of the dystrophin-associated protein complex (DPC), which consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and alpha- and beta-dystrobrevin. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Mutations in this gene are associated with left ventricular noncompaction with congenital heart defects. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene.
-
Poids moléculaire
- 58.7 kDa
-
ID gène
- 1837
-
NCBI Accession
- NM_032979
-
HGNC
- 1837
Antigène
-